Hep C Drugs in 2016: More Combos and Lower Cost
While some exciting new drug combos are on the approval horizon, cost concerns will drive interest in Hepatitis C treatment for 2016.
Continue reading »While some exciting new drug combos are on the approval horizon, cost concerns will drive interest in Hepatitis C treatment for 2016.
Continue reading »Find out about the new antiviral drug in development that comes from...bananas?
Continue reading »FixHepC helps Hepatitis C patients obtain crucial drugs at extremely low prices.
Continue reading »The FDA reported that AbbVie's Hepatitis C drugs have been linked to many cases of serious liver damage.
Continue reading »Find out three common policies that insurance companies generally use to limit access for Hepatitis C patients to direct-acting antivirals.
Continue reading »Learn more about Gilead's drug combination of velpatasvir and sofosbuvir, which is proving to be extremely effective in recent trials of clearing all strains of Hepatitis C.
Continue reading »Greg Jefferys has taken matters into his own hands, and has provided a supply of medication from India to hundreds of patients suffering from Hepatitis C.
Continue reading »Learn more about a Hepatitis C vaccine being produced at the National Centre for Bio-formulas (BIOCEN) in Cuba.
Continue reading »Find out about Merck’s chronic HCV treatment candidate grazoprevir/elbasvir.
Continue reading »Learn more about Technivie, a new Hepatitis C treatment approved by the FDA.
Continue reading »You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window